🇺🇸 FDA
Pipeline program

VX-150

VX16-150-102

Phase 2 small_molecule completed

Quick answer

VX-150 for Small Fiber Neuropathy is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Small Fiber Neuropathy
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials